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Abstract
We introduce a family of positive definite kernels specifically optimized for the manipulation of 3D structures
of molecules with kernel methods. The kernels are based on the comparison of the three-points pharmacophores
present in the 3D structures of molecules, a set of molecular features known to be particularly relevant for virtual
screening applications. We present a computationally demanding exact implementation of these kernels, as well as
fast approximations related to the classical fingerprint-based approaches. Experimental results suggest that this new
approach outperforms state-of-the-art algorithms based on the 2D structure of molecules for the detection of inhibitors
of several drug targets.
1 Introduction
Virtual screening refers to the process of inferring biological properties of molecules in silico, and plays an increas-
ingly important role at the early stages of the drug discovery process to select candidate molecules with promising
drug-likeness, including good toxicity and pharmacokinetics properties, as well as the potential to bind and inhibit a
target protein of interest (1). In this context, structure-activity relationship (SAR) analysis is commonly used to build
predictive models for the property of interest from a description of the molecules, using statistical procedures to build
these models from the analysis of molecules with known properties (2).
It is widely accepted that several drug-like properties can be efficiently deduced from the 2D structure of the
molecule, that is, the description of a molecule as a set of atoms and their covalent bonds. For example, Lipinski’s
“rule of five” remains a widely used standard for the prediction of intestinal absorption (3), and the prediction of
mutagenicity from 2D molecular fragments is an accurate state-of-the-art approach (4). In the case of target binding
prediction, however, the molecular mechanisms responsible for the binding are known to depend on a precise 3D
complementarity between the drug and the target, from both the steric and electrostatic perspectives (5). For this
reason, there has been a long history of research on the prediction of these interactions from the 3D representation of
molecules, that is, their spatial conformation in the 3D space. If the 3D structure of the target is known, the strength
of the interaction can be directly evaluated by docking techniques, that quantify the complementarity of the molecule
to the target in terms of energy (6). In the general case where the 3D structure of the target is unknown, however, the
docking approach is not possible anymore and the modeler must resort to creating a predictive model from available
data, typically a pool of molecules with known affinity to the target; this approach is usually referred to as the ligand-
based approach to virtual screening.
Most approaches to ligand-based virtual screening require to represent and compare 3D structures of molecules.
The comparison of 3D structures can for example rely on optimal alignments in the 3D space (7), or on the comparison
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Figure 1: The kernel trick: instead of looking for, e.g., a separating hyperplane directly in the input space X , training
patterns (white and black disks) are mapped into a feature space H through a function φ in which a hyperplane is
computed; this hyperplane might correspond to a complex surface in the input space. Using a proper positive definite
kernel k when carrying out the computations to derive the separating hyperplane is equivalent to directly working with
the images of the training samples by some mapping φ from X to some feature space H; the existence of φ : X → H
is guaranteed by (3).
of features extracted from the structures (8). Features of particular importance in this context are subsets of two to
four atoms together with their relative spatial organization, also called pharmacophores. Discovering pharmacophores
common to a set of known inhibitors to a drug target can be a powerful approach to the screening of other candidate
molecules containing the pharmacophores, as well as a first step towards the understanding of the biological phe-
nomenon involved (9; 10). Alternatively, pharmacophore fingerprints, that is, bitstrings representing a molecule by
the pharmacophores it contains, has emerged as a potential approach to apply statistical learning methods for SAR,
although sometimes with mixed results (11; 12; 13).
We focus in this paper on an extension of the fingerprint representation of molecules for building SAR models
with support vector machines (SVM). SVM is an algorithm for learning a classification or regression rule from labeled
examples (14; 15), that has recently been subject to much investigations for SAR applications in chemoinformatics
(16; 17; 18; 19). Although SVM can be trained from a vector or bitstring representation of molecules, they can also
take advantage of a mathematical trick to only rely on a measure of similarity between molecules, known as kernel.
This trick, common to other algorithms called kernel methods (20), was for example used in (21; 18) to build SAR
models from a 2D fingerprint of molecules of virtually infinite length. Here we investigate the possibility to use this
trick in the context of 3D SAR modeling. We propose a measure of similarity between 3D structures, which we
call the pharmacophore kernel, based on the comparison of pharmacophores present in the structures. It satisfies the
mathematical properties required to be a valid kernel and it therefore allows the use of SVM for model building. This
kernel bears some similarity with pharmacophore fingerprint approaches, although it produces more general models.
In fact, we show that a fast approximation of this kernel, based on pharmacophore fingerprints, leads to significantly
lower performance on a benchmark dataset. We also show that competitive performance can be obtained by a fast
fingerprint-based approximation using the Tanimoto coefficient as a valid kernel for SVM (19). The overall good
performance of the approach on this benchmark supports its relevance as a potentially effective tool for 3D SAR
modeling.
This paper is organized as follows. A light introduction to SVM and kernel methods is provided in Section 2,
followed by the definition of the pharmacophore kernel (Section 3). The exact computation of this kernel is presented
in Section 4, followed by a discussion about the connection between the pharmacophore kernel and recently intro-
duced graph kernels (Section 5) and the presentation of a fast approximation (Section 6). Experimental results on a
benchmark dataset for inhibitor prediction are then presented in Section 7, followed by a short discussion.
2 Support vector machines
In this section we briefly review the basics of support vector machines (14; 15). The interested reader is invited to
refer to (22; 20; 23) for further details. In its simplest form SVM is an algorithm to learn a binary classification rule
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from a set of labeled examples. More formally, suppose one is given a set of examples with a binary label attached to
each example, that is, a set S = {(x1, y1), . . . , (xℓ, yℓ)} where (xi, yi) ∈ X × {−1,+1} for i = 1, . . . , ℓ. Here X is
an inner-product space (e.g. Rd), equipped with inner product 〈·, ·〉, that represents the space of data to be analyzed,
typically molecules represented by d-dimensional fingerprints, and the labels +1 and −1 are meant to represent two
classes of objects, such as inhibitors or non-inhibitors of a target of interest. The purpose of SVM is to learn from S a
classification function f : X → {−1,+1} that can be used to predict the class of new unlabeled examples x as f(x).
In the case of SVM, the classification function is simply of the form f(x) = sign(〈w, x〉 + b), where sign(·)
is the function returning the sign, +1 or −1, of its argument. Geometrically speaking, this means that f outputs a
prediction for a pattern x depending upon which side of the hyperplane 〈w, x〉 + b = 0 it falls in. More precisely,
SVM learn a separating hyperplane from S defined by a vector w that is a linear combination of the training vectors
w =
∑ℓ
i=1 αixi, for some αi ∈ R, i = 1, . . . , ℓ, obtained by solving a linearly constrained quadratic problem meant to
optimize a trade-off between finding a hyperplane that correctly separates all the points, while being as far as possible
from each point. The linear classifier f can consequently be rewritten as
f(x) = sign
(
ℓ∑
i=1
αi〈xi, x〉+ b
)
. (1)
However, when dealing with nonlinearly separable problems, such as the one depicted on Figure 1 (left), the set
of linear classifiers may not be rich enough to provide a good classification function, no matter what the values of the
parameters w ∈ X and b ∈ R are. The purpose of the kernel trick (24; 14), is precisely to overcome this limitation
by applying a linear approach to the transformed data φ(x1), . . . , φ(xℓ) rather than the original data, where φ is an
embedding from the input space X to the feature space H, usually, but not necessarily, a high-dimensional space,
equipped with dot product 〈·, ·〉H. Thus, according to (1), the separating function f writes as
f(x) = sign
(
ℓ∑
i=1
αi〈φ(xi), φ(x)〉H + b
)
. (2)
The key ingredient in the kernel approach is to replace the dot product in H with a kernel, using the definition of
positive definite kernels.
Definition 1 (Positive definite kernel). Let X be a nonempty space. Let K : X × X → R be a symmetric function.
K is said to be a positive definite kernel if and only if, for all ℓ ∈ N, for all x1, . . . , xℓ ∈ X , the square ℓ × ℓ matrix
K = (K(xi, xj))1≤i,j≤ℓ is positive semi-definite, that is, all its eigenvalues are nonnegative.
For a given set Sx = {x1, . . . , xℓ}, K is the Gram matrix of K with respect to Sx. A fundamental property of
positive definite kernels that underlies the kernel trick is the fact that each such kernel can be represented as an inner
product in some space. More precisely, it can be shown (25) that for any positive definite kernel function K , there
exists a space H, equipped with the inner product 〈·, ·〉H, and a mapping φ : X → H such that:
∀u, v ∈ X K(u, v) = 〈φ(u), φ(v)〉H . (3)
The kernel trick consists in replacing all occurrences of 〈·, ·〉H in (2) by a positive definite kernel K such that the
corresponding decision function f , for an input pattern x, is given by:
f(x) = sign
(
ℓ∑
i=1
αiK(xi, x) + b
)
. (4)
For SVM as well as for other kernel methods, the knowledge of the Gram matrix suffices to obtain the coefficients αi.
For any given positive definite kernel, applying the kernel trick turns out to be equivalent to transforming the
input patterns x1, . . . , xℓ into the corresponding vectors φ(x1), . . . , φ(xℓ) ∈ H and to look for hyperplanes in H,
as illustrated in Figure 1 (middle). The decision surface in input space X corresponding to the selected separating
hyperplane in H might be quite complex (see Figure 1, right).
A noteworthy feature of support vector machines and more generally of kernel methods (23) is that, since ready-
to-use libraries to derive separating hyperplanes are available, the only requirement for them to be applied to a specific
classification problem is to have at hand a proper kernel function to assess the similarity between patterns of the input
space considered. Henceforth, their use actually fit in the framework of classification problems involving structured
data such as chemical compounds, provided some kernel function has been derived. The rest of the paper is devoted
to the construction and analysis of such a kernel for 3D structures of molecules.
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Figure 2: Left: a 3-points pharmacophore made of one hydrogen bond acceptor (topmost sphere) and two aromatic
rings, with distances d1, d2 and d3 between the features. Middle: the molecule of flavone. Right: match between
flavone and the pharmacophore.
3 The pharmacophore kernel
A pharmacophore is usually defined as a three-dimensional arrangement of atoms - or groups of atoms - responsible for
the biological activity of a drug molecule (26). The present work focuses on three-points pharmacophores, composed
of three atoms whose arrangement therefore forms a triangle in the 3D space (Figure 2). With a slight abuse we
refer as pharmacophore below to any possible configuration of three atoms or classes of atoms arranged as a triangle
and present in a molecule, representing therefore a putative configuration responsible for the biological property of
interest.
Throughout this paper we represent the 3D structure of a molecule as a set of points in R3. These points correspond
to the 3D coordinates of the atoms of the molecule (for a given arbitrary basis of the 3D Euclidean space), and they
are labeled with some information related to the atoms. More formally, we define a molecule m as
m =
{
(xi, li) ∈ R
3 × L
}
i=1,...,|m |
,
where |m | is the number of atoms that compose the molecule and L denotes the set of atom labels. The label is meant
to contain the relevant information to characterize a pharmacophore based on atoms, such as the type of atom (C, N, O,
...) and its partial charge. The three-points pharmacophores considered in this work correspond to triplets of distinct
atoms of the molecules. The set of pharmacophores of the molecule m can therefore be formally defined as:
P(m) =
{
(p1, p2, p3) ∈ m
3, p1 6= p2 6= p3
}
.
More generally, the set of all possible pharmacophores is naturally defined as P =
(
R
3 × L
)3
, to ensure the inclusion
P(m) ⊂ P . We can now define a general family of kernels for molecules based on their pharmacophore content:
Definition 2. For any positive definite kernel for pharmacophores KP : P × P → R, we define a corresponding
pharmacophore kernel for any pair of molecules m and m′ by :
K(m,m′) :=
∑
p∈P(m)
∑
p′∈P(m′)
KP(p, p
′) , (5)
with the convention that K(m,m′) = 0 if either P(m) or P(m′) is empty.
The fact that the pharmacophore kernel defined in (5) is a valid positive definite kernel on the set of molecules,
as soon as KP is itself a valid positive definite kernel on the set of pharmacophores, is a classical result (see, e.g.,
(27, Lemma 1)). The problem of constructing a pharmacophore kernel for molecules therefore boils down to the
simpler problem of defining a kernel between pharmacophores. A chemically relevant measure of similarity between
pharmacophores should obviously quantify at least two features: first, similar pharmacophores should be made of
similar atoms, and second, the atoms should have similar relative positions in the 3D space. It is therefore natural to
study kernels for pharmacophores that decompose as follows:
KP(p, p
′) = KI(p, p
′)×KS(p, p
′) , (6)
where KI is a kernel function assessing the similarity between the triplets of basis atoms of the pharmacophores (their
so-called intrinsic similarity), and KS is a kernel function introduced to quantify their spatial similarity.
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We can furthermore investigate intrinsic and spatial kernels that factorize themselves as products of more basic
kernels between atoms and pairwise distances, respectively. Triplets of atoms are indeed globally similar if the three
corresponding pairs of atoms are simultaneously similar, and triangles are similar if the lengths of their edges are
pairwise similar. For any pair of pharmacophores p = ((xi, li))i=1,2,3 and p′ = ((x′i, l′i))i=1,2,3, this suggests to
define kernels as follows:
KI(p, p
′) =
3∏
i=1
KFeat (li, l
′
i) , (7)
KS(p, p
′) =
3∏
i=1
KDist
(
‖ xi − xi+1 ‖, ‖ x
′
i − x
′
i+1 ‖
)
, (8)
where ‖ . ‖ denotes the Euclidean distance, the indices i are taken modulo 3, andKFeat andKDist are kernels functions
introduced to compare pairs of labels from L, and pairs of distances, respectively. It suffices now to define the kernels
KFeat on L × L and KDist on R × R in order to obtain, by (5), (6), (7) and (8), a pharmacophore kernel for
molecules. The first one compares the atom labels, while the second compares the distances between atoms in the
pharmacophores. Intuitively they define the basic notions of similarity involved in the pharmacophore comparison,
which in turns defines the overall similarity between molecules.
The kernel we use for KDist is the Gaussian radial basis function (RBF) kernel, known to be a safe default choice
for SVM working on real numbers or vectors (20):
KRBFDist (x, y) = exp
(
−
||x− y||2
2σ2
)
, (9)
where σ > 0 is the bandwith parameter that will be optimized as part of the training of the classifier (see Section 7.2).
Concerning the kernel KFeat between labels, we investigate several choices. The labels belonging in principle to
a finite set of possible labels, e.g., the set of atom types with their charges (C, C+, C−, N, ...), the following Dirac
kernel is a natural default choice to compare a pair of atom labels l, l′ ∈ L :
KDiracFeat (l, l
′) =
{
1 if l = l′ ,
0 otherwise .
(10)
Alternatively, it might be relevant for pharmacophore definition to compare atoms not only on the basis of their
types and partial charges, but also in terms of other physicochemical parameters such as their size, polarity and
electronegativity. Formally, a physicochemical parameter for an atom with label l is a real number f(l). In that case,
the Gaussian RBF kernel (9) could be applied directly to the parameter values to compare labels. A practical drawback
of this kernel, however, is that it never vanishes. This induces an important computational burden compared to the
Dirac kernel (see Section 4). As a result, we prefer to use the related triangular kernel:
KTriFeat(l, l
′) =
{
C−||f(l)−f(l′)||
C
if ||f(l)− f(l′)|| ≤ C ,
0 otherwise .
(11)
An important difference between the Gaussian RBF and triangular kernels lies in the fact that the triangular kernel
has a compact support, which means that it can be equal to 0 for different atoms, resulting in important computational
gain. The parameter C, to be optimized during the training phase of the algorithm, represents the range beyond which
the kernel vanishes.
Note finally that the Gaussian RBF (9), triangular (11), and Dirac (10) kernels are known to be positive definite
(20), and it follows from the closure properties of the family of kernel functions, that the kernel between pharma-
cophores KP is valid for any choice of the kernels KDist and KFeat proposed above.
4 Kernel computation
We are now left with the task of computing the pharmacophore kernel (5) for a particular choice of feature and distance
kernels KFeat and KDist. In this section we provide a simple analytical formula for this computation.
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For any pair of molecules m =
{
(xi, li) ∈ R
3 × L
}
i=1,...,|m|
and m′ =
{
(x′i, l
′
i) ∈ R
3 × L
}
i=1,...,|m′|
, let us
define a square matrix M of size n = |m| × |m′|, whose dimensions are indexed by the Cartesian product of m and
m′. In other words, to each index i ∈ [1, n] corresponds a unique couple of indices (i1, i2) ∈ [1, |m|]× [1, |m′|], and
to each dimension of the matrix M corresponds a distinct pair of points taken from the moleculesm and m′. Denoting
by 1 (.) the indicator function equal to one if its argument is true, zero otherwise, the entries of M are defined by:
M [i, j] = M [(i1, i2), (j1, j2)]
= KFeat
(
li1 , l
′
i2
)
×KDist
(
||xi1 − xj1 ||, ||x
′
i2
− x′j2 ||
)
× 1 (i1 6= j1)× 1 (i2 6= j2) . (12)
The value of the pharmacophore kernel between m and m′ can now be deduced from the matrix M by the following
result:
Proposition 1. The pharmacophore kernel (5) between a pair of molecules m and m′ is equal to:
K(m,m′) = trace(M3) ,
where M is the square matrix of dimension |m | × |m′ | constructed from m and m′ by (12).
Proof. Developing the matrix products involved in the expression of M3 we get
trace(M3) =
n∑
i,j,k=1
M [i, j]M [j, k]M [k, i] ,
where n = |m| × |m′| is the size of M . Using the fact that the indices of M ranges over the Cartesian product of the
set of indices [1, |m|] and [1, |m′|], we can rewrite this expression as :
trace(M3) =
|m|∑
i1,j1,k1=1
|m′|∑
i2,j2,k2=1
M [(i1, i2), (j1, j2)]M [(j1, j2), (k1, k2)]M [(k1, k2), (i1, i2)] .
Substituting with the definition of M given in (12), we obtain :
trace(M3) =
|m|∑
i1,j1,k1=1
|m′|∑
i2,j2,k2=1
1 (i1 6= j1)1 (j1 6= k1)1 (k1 6= i1)× 1 (i2 6= j2)1 (j2 6= k2)1 (k2 6= i2)
×KFeat
(
li1 , l
′
i2
)
×KDist
(
||xj1 − xi1 ||, ||x
′
j2
− x′i2 ||
)
×KFeat
(
lj1 , l
′
j2
)
×KDist
(
||xk1 − xj1 ||, ||x
′
k2
− x′j2 ||
)
×KFeat
(
lk1 , l
′
k2
)
×KDist
(
||xi1 − xk1 ||, ||x
′
i2
− x′k2 ||
)
=
|m|∑
i1,j1,k1=1
|m′|∑
i2,j2,k2=1
1 (i1 6= ji 6= k1)× 1 (i2 6= j2 6= k2)
×KP
(
((xi1 , li1), (xj1 , lj1), (xk1 , lk1)) ,
(
(x′i2 , l
′
i2
), (x′j2 , l
′
j2
), (x′k2 , l
′
k2
)
))
=
|m|∑
i1,j1,k1=1,
i1 6=j1 6=k1
|m′|∑
i2,j2,k2=1,
i2 6=j2 6=k2
KP
(
((xi1 , li1), (xj1 , lj1), (xk1 , lk1)) ,
(
(x′i2 , l
′
i2
), (x′j2 , l
′
j2
), (x′k2 , l
′
k2
)
))
=
∑
p∈P(m)
∑
p′∈P(m′)
KP(p, p
′)
= K(m,m′) .
If we neglect the cost of the addition and product operations, and let u be that of evaluating the basis kernels
KFeat and KDist, the complexity of the kernel between pharmacophores KP is 6u. Since the cardinality of the set
of pharmacophore P(m) of the molecule m is |m|3, the complexity of the direct computation of the pharmacophore
kernel given in definition 2 is (|m| × |m′|)3 × 6u. On the other hand, the computation given in Proposition 1 is a two
step process :
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• first, initialization of the matrix M : each of the (|m| × |m′|)2 entries is initialized by the product of a kernel
KFeat with a kernel KDist, for a complexity of (|m| × |m′|)2 × 2u
• second, computation of the trace of M3, which has a complexity of (|m| × |m′|)3
The global complexity of the matrix-based computation of the kernel is therefore (|m| × |m′|)3 +(|m| × |m′|)2 × 2u,
or equivalently (|m| × |m′|)3 × (1 + 2u/(|m| × |m′|)). In comparison with the direct approach, the matrix-based
implementation proposed in Proposition 1 reduces the number of basis kernels KDist and KFeat to be computed and
is therefore more efficient.
In any case, the complexity of the pharmacophore kernel computation is therefore O
(
(|m| × |m′|)
3
)
. Even for
relatively small molecules (of the order of 50 atoms), this complexity becomes in practice a serious issue when the size
of the dataset increases to thousands or tens of thousands of molecules. However, we can note from the definition given
in (12), that the lines of M corresponding to pairs of points (x, l) ∈ m and (x′, l′) ∈ m′ for which KFeat(l, l′) = 0
are filled with zeros. Based on this consideration, we observe that the cost of computing the kernel can be reduced by
limiting the size of the matrix M , according to the following proposition.
Proposition 2. If we let M2 be the reduced version of a square matrix M1, where the null lines and the corresponding
columns are removed, then trace(M32 ) = trace(M31 ).
Proof. Let n1 (resp. n2) be the size of M1 (resp. M2), and define P (resp. N ) as the subset of the set of indices [1, n1]
that corresponds to the non-null (resp. null) lines of M1. By definition, we have
trace(M31 ) =
n1∑
i=1
M31 [i, i]
=
n1∑
i,j,k=1
M1[i, j]M1[j, k]M1[k, i] . (13)
Moreover, if i ∈ N , then M1[i, j] = 0 ∀j ∈ [1, n1]. As a consequence, the term M1[i, j]M1[j, k]M1[k, i] in the
summations over i, j, and k in (13) is zero as soon as at least one index i, j or k is in the set N . It follows that
trace(M31 ) =
∑
i,j,k∈P
M1[i, j]M1[j, k]M1[k, i]
=
n2∑
i,j,k=1
M2[i, j]M2[j, k]M2[k, i]
= trace(M2) .
Proposition 2 implies that the Cartesian product of m and m′ involved in the matrix M defined in (12) can be
restricted to the pairs of points for which the label kernel KFeat is non-zero. In the case of the Dirac kernel (10) for
discrete labels, this boils down to introducing a dimension in M for any pair of atoms having the same label. This
result can have important consequences in practice. Consider for example the case where the atoms of the molecules
m and m′ are uniformly distributed in k classes of atom labels. In this case, the size of the matrix M is equal to
k (|m|/k × |m′|/k) = |m| × |m′|/k. The complexity of the kernel computation is therefore O
(
(|m| × |m′|/k)3
)
=
O
(
(1/k3)(|m| × |m′|)3
)
. It is therefore reduced by a factor k3 in comparison with the original implementation.
More generally this shows that important gains in memory and computation can be expected when the set of labels
is increased. Section 7.3 discusses such a case in more details when the partial charges of atoms are included or not
in the labels. This also justifies why the triangular kernel (11), with its compact support, can lead to much faster
implementations than the Gaussian RBF kernel (9) when applied to the comparison of physicochemical properties of
atoms. Finally, in a similar way, the kernel KDist to compare distances can be set to a compactly supported kernel,
such as the triangular kernel (11). This has the effect of introducing sparsity in the matrix M , allowing the kernel
computation to benefit from sparse matrix algorithms. This possibility was not further explored in this work.
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5 Relation with graph kernels
In this section we show that the pharmacophore kernel can be seen as an extension of the walk-count graph kernels
(28) to the 3D representation of molecules. The walk-count graph kernel is based on the representation of a molecule
m as a labeled graph m = (V , E), defined by a set of vertices V , a set of edges E ⊂ V × V connecting pairs of
vertices, and a labeling function l : V ∪ E → A, assigning a label l(x) in an alphabet A to any vertex or edge x. In
the case of molecules, the set of vertices V corresponds to the atoms of the molecule, and the edges of the graph are
usually defined as the covalent bonds between the atoms of the molecules (28; 21; 18). In order to extend this 2D
representation to a graph structure capturing 3D information, we propose to introduce an edge between any pair of
vertices of the graph. Molecules are therefore seen as complete, atom-based graphs. If we now define a walk of length
n as a succession of n + 1 connected vertices, it is easy to see that there is a one-to-one correspondence between the
set of pharmacophoresP(m) of a molecule m, and its set of self-returning walks of length-three, that we call W3(m).
We can therefore write the pharmacophore kernel (5) as a walk-based graph kernel :
K(m,m′) =
∑
p∈P(m)
∑
p′∈P(m′)
KP(p, p
′) =
∑
w∈W3(m)
∑
w′∈W3(m′)
KWalk(w,w
′) ,
where KWalk(w,w′) = KP (p, p′) for the pair of walks (w,w′) corresponding to the pair of pharmacophores (p, p′).
More precisely, consider a pair of pharmacophores p = ((xi, li))i=1,2,3 and p′ = ((x′i, l′i))i=1,2,3, and a corresonding
pair of walksw = (w1, w2, w3, w1) andw′ = (w′1, w′2, w′3, w′1). There is a direct equivalence betweenKP andKWalk
if we choose to label the vertices of the graphs by the atom labels involved in the pharmacophore characterization, and
to label the edges by the Euclidian distance between the atoms they connect. Indeed, in this case we can write :
KP(p, p
′) =
3∏
i=1
KFeat (li, l
′
i)KDist
(
‖ xi − xi+1 ‖, ‖ x
′
i − x
′
i+1 ‖
)
=
3∏
i=1
KFeat (l(wi), l(w
′
i))KDist
(
l ((wi, wi+1)) , l
(
(w′i, w
′
i+1)
))
= KWalk(w,w
′)
A striking point of this kernel between walks is that it can be factorized along the edges of the walks :
KWalk(w,w
′) =
3∏
i=1
KFeat (l(wi), l(w
′
i))KDist
(
l ((wi, wi+1)) , l
(
(w′i, w
′
i+1)
))
=
3∏
i=1
KStep
(
(wi, wi+1), (w
′
i, w
′
i+1)
) (14)
The pharmacophore kernel therefore formulates as a walk-based graph kernel, with a walk kernel factorizing along
the edges of the walks. It follows from (21) that it can be computed by the formalism based on product-graphs and
powers of the adjacency matrix proposed in (28), if the adjacency matrix of the product-graph is weighted by the walk-
step kernels KStep (14). Consequently, the matrix M defined in (12) and upon which is based the kernel computation
of Proposition 1, can be seen as a weighted adjacency matrix of a product-graph defined on complete, atom-based,
molecular factor graphs.
6 Fast approximation
As an alternative to the costly computation presented in Section 4, we introduce in this section several fast approxima-
tions to the pharmacophore kernel based on a discretization of the pharmacophore space.
Our definition of pharmacophores is based on the atoms 3D coordinates, but they can equivalently be characterized
by the pairwise distances between atoms. In order to define discrete pharmacophores, we restrict ourselves to discrete
sets of atom labels (e.g., the set of atom types), and we discretize the range of distances between atoms into a predefined
number of bins. Each distance is then mapped to the index of the bin it falls in, and a discrete pharmacophore is defined
by a triplet of atom labels together with a triplet of bin indices. More formally, if the distance range is discretized into
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p bins, the set of discrete pharmacophores is a finite set defined as T3 = L3× [1, p]3, where L is the set of atom labels.
Consider the mappings φ3pt0 and φ
3pt
1 from the set of molecules to the set of discrete pharmacophores T∋, defined for
the molecule m as :
• φ3pt0 (m) = (φt,0(m))t∈T3 , where φt,0(m) is the number of times the pharmacophore t is found in the molecule
m,
• φ3pt1 (m) = (φt,1(m))t∈T3 , where φt,1(m) equals 1 if the pharmacophore t is found in the molecule m, and 0
otherwise.
With these new definitions at hand we propose three discrete kernels,
Definition 3 (Three-points spectrum kernel). For a pair of moleculesm and m′, we define the three-points spectrum
kernel K3ptSpec as
K3ptSpec(m,m
′) = 〈φ3pt0 (m), φ
3pt
0 (m
′)〉 =
∑
t∈T3
φt,0(m)φt,0(m
′) . (15)
Note that if we define the mapping d : P 7→ T3, such that d(p) is the discretized version of the pharmacophore
p ∈ P , we can explicitly write the three-points spectrum kernel as a particular pharmacophore kernel (5):
K3ptSpec(m,m
′) =
∑
p∈P(m)
∑
p′∈P(m′)
1 (d(p) = d(p′)) .
This equation shows that this is a crude pharmacophore kernel, based on a kernel for pharmacophores that simply
checks if two given pharmacophores have identical discretized versions or not.
Definition 4 (Three-points binary kernel). For a pair of molecules m and m′, we define the three-points binary
kernel K3ptBin as
K3ptBin(m,m
′) = 〈φ3pt1 (m), φ
3pt
1 (m
′)〉 =
∑
t∈T3
φt,1(m)φt,1(m
′) . (16)
Definition 5 (Three-points Tanimoto kernel). For a pair of moleculesm andm′, we define the three-points Tanimoto
kernel K3ptTani as
K3ptTani(m,m
′) =
K3ptBin(m,m
′)
K3ptBin(m,m) +K
3pt
Bin(m
′,m′)−K3ptBin(m,m
′)
. (17)
Note that the mappingφ3pt1 (m) corresponds to a classical pharmacophore fingerprint representation of the molecule
m, where the bitstring is indexed by the pharmacophores of T3. As a result, the three-points Tanimoto kernel is the
equivalent of the Tanimoto coefficient for pharmacophore fingerprints, and constitutes a standard pharmacophore-
based similarity measure (29; 30; 12). Note that the dimensionality of the feature spaces associated to these kernels
corresponds to the cardinality of T3, which is by definition (np)3 for a label set L of cardinality n and p distance bins.
Finally, we consider additional “two-points pharmacophore” versions of the kernels (15), (16) and (17), based
on pairs, instead of triplets, of atoms (19). Letting T2 be the set of all possible two-points pharmacophores, that is,
pairs of atom types together with the bin index of the edge connecting them, and φ2pt0 (m) = (φt,0(m))t∈T2 and
φ2pt1 (m) = (φt,1(m))t∈T2 be the mappings of the molecule m to T2, corresponding to φ
3pt
0 (m) and φ
3pt
1 (m), we
define the three following kernels.
Definition 6 (Two-points spectrum kernel). For a pair of molecules m and m′, we define the two-points spectrum
kernel K2ptSpec as :
K2ptSpec(m,m
′) = 〈φ2pt0 (m), φ
2pt
0 (m
′)〉 =
∑
t∈T2
φt,0(m)φt,0(m
′) . (18)
Definition 7 (Two-points binary kernel). For a pair of molecules m and m′, we define the two-points binary kernel
K2ptBin as :
K2ptBin(m,m
′) = 〈φ2pt1 (m), φ
2pt
1 (m
′)〉 =
∑
t∈T2
φt,1(m)φt,1(m
′) . (19)
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Definition 8 (Two-points Tanimoto kernel). For a pair of molecules m and m′, we define the two-points Tanimoto
kernel K2ptTani as :
K2ptTani(m,m
′) =
K2ptBin(m,m
′)
K2ptBin(m,m) +K
2pt
Bin(m
′,m′)−K2ptBin(m,m
′)
. (20)
The following proposition justifies the use of these fast kernels with SVM:
Proposition 3. The kernels (15), (16), (17), (18), (19) and (20) are positive definite.
Proof. Kernels (15), (16), (18), (19) are directly expressed as dot-products, and are consequently positive definite.
Kernels (17) and (20) follow the definition of the Tanimoto kernel which is known to positive definite (19).
The kernels (15), (16), (17), (18), (19) and (20) can be computed efficiently using an algorithm derived from that
used in the implementation of spectrum string kernels (31). We describe this algorithm in the case of the three-points
kernels (15), (16) and (17), its extension to the two-points kernels (18), (19) and (20) being straightfoward. Following
the notation of Section 5, we represent molecules by complete, atom-based labeled graphs, with the difference that the
set of atom labels L defining the vertices labels is considered to be discrete (e.g., the atom types), and the edges are
now labeled by the bin index of the corresponding inter-atomic distance. We consider the problem of computing the
Gram matrix K associated to such a set of molecular graphs
{
Gi = (VGi , EGi)
}
i=1,...,n
for the kernels (15), (16) and
(17). The alphabet A, involved in the graph labeling function l of section 5, is defined as A = LV ∪LE , where LV is
the set of vertices labels, corresponding to the set of atom labels L, and LE is the set of edges labels, corresponding to
the set of distance bins indices.
The algorithm is based on the manipulation of sets of walk pointers within each graph, according to a tree transver-
sal process. If we let n and p be the cardinalities of LV and LE respectively, we define a rooted, depth-four tree
structuring the space of pharmacophores T3 as follows :
• the root node has n sons, corresponding to the n possible vertex labels
• the depth-one and depth-two nodes have n×p sons, corresponding to the n×p possible pairs of edge and vertex
labels
• the depth-three nodes have p sons, corresponding to the p possible edges labels, a leaf node being implicitly
associated the vertex label of its depth-one ancestor.
A path from the root to a leaf node therefore corresponds to a triplet of disctinct vertex labels, together with a triplet of
distinct edge labels. There is therefore a one-to-one correspondence between the leaf nodes and the pharmacophores
of T3. The principle of the algorithm is to recursively transverse this tree until each leaf node (i.e., each potential
pharmacophore) is visited. During this process, a set of walk pointers is maintained within each molecule. The
pointers are recursively updated such that the pointed walks correspond to the pharmacophores under construction in
the tree-transversal process. When reaching a leaf node, the pointed walks correspond to the occurences of a particular
pharmacophore t in the molecules. The mappings φt,0(Gi) and φt,1(Gi) can therefore be computed for the molecular
graphs {Gi}i=1,...,n, and the kernel matrix can be updated.
A pseudo code of the algorithm is given in Algorithms 1, 2, 3 and 4. Algorithm 1 is the main program in charge
of the tree-transveral process, and Algorithms 2, 3 and 4 are subroutines, introduced to initialize the walks pointers,
extend the pointed walks, and update the Gram matrix respectively. This pseudo-code relies on the abstract types
Pointer and Label, to represent the walk pointers involved in the algorithm, and the generic vertices and edges labels,
belonging to LV and LN respectively. Formally, a Pointer object consists of two graph vertices: a start and current
vertex, representing the first and the current vertices of the pointed walk being extended. To maintain walks pointers
within each molecule, we introduce a matrix of pointers walkPointers = Pointer[][] : this matrix is initially empty,
and during the walk extension process, walkPointers[i][j] corresponds to the jth pointer of the molecular graph Gi.
The stopping criterion of the recursion is controled by an integer variable depth corresponding to the depth in the tree
during the transversal process. It is initialized to zero and incremented at each recursive call. When depth is three,
a depth-three node was reached in the tree, which corresponds to pointers on length-two walks in the graphs. In the
subsequent recursive step, depth is four, and the pointers are updated to ensure that the extended walks correspond
to self-returning ones. A leaf node is then reached and the recursion terminates, leading to an update of the Gram
matrix. Note however that the recursion is aborted whenever the set of walk pointers becomes empty for all graphs,
since we only need to reach the leaf nodes corresponding to the pharmacophores truly present in the set of graphs.
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The Gram matrix is updated according to the spectrum (15), binary (16) or Tanimoto (17) definition of the kernel, and
we introduce a n× n Gram matrix K , initialized to zero, together with a binary variable kernelType that can take the
values ’spectrum’, ’binary’ or ’Tanimoto’.
Computing the Gram matrix K simply requires a call to the COMPUTE function of Algorithm 1 with these initial-
ized data : COMPUTE(walkPointers, depth, K, kernelType), for a specified kernelType, and where the Pointer array
walkPointers is empty, depth equals zero and the Gram matrix K is filled with zeros. Note however that in the case
of the Tanimoto kernel type, this procedure computes the ’raw’ kernel that actually corresponds to the binary kernel
(16). The matrix K must be further normalized according to defintion 5, that is : K[i][j] = K[i][j]
K[i][i]+K[j][j]−K[i][j] .
The cost of this algorithm depends on the number of leaf nodes visited, and is therefore bounded by the total
number of leaves of the tree, that is (np)3 if the number of distinct vertex labels is n and the number of distance bins is
p. However, the maximum number of distinct pharmacophores that can be found in the molecule m is |m|3, and we do
not need to exhaustively transverse the tree. This means that to compute the kernel between the molecules m and m′,
at most min(|m|3, |m′|3) leaves, corresponding to the common pharmacophores of m and m′, need to be visited. The
complexity of the algorithm is therefore O
(
min
(
(np)3,min
(
|m|3, |m′|3
)))1
. For small molecules, the cost of the
kernel will therefore depend on their number of atoms, while it will depend on the size of the discrete pharmacophores
space for large molecules.
Note finally that although we omit the details, the previous algorithm and complexity analysis hold for the two-
points versions of the kernels : the tree involved in the recursive transversal process is smaller (a depth-two tree, with
n2p leaf nodes), and the complexity is reduced to O (min (n2p,min(|m|2, |m′|2))).
Algorithm 1 main program
COMPUTE(Pointer[][] walkPointers,Integer depth, Float[][] K , String kernelT ype)
depth = depth+ 1
if depth = 1 then
for label ∈ LV do
walkPointers = initPointers(label)
compute(walkPointers, depth)
end for
else
for label1 ∈ LV do
for label2 ∈ LE do
walkPointers = extendPointers(walkPointers, depth, label1, label2)
if iwalkPointers 6= [][] then
if depth = 4 then
updateGram(walkPointers,K, kernelT ype)
else
compute(walkPointers, depth)
end if
end if
end for
end for
end if
7 Experiments
We now turn to the experimental section. The problem considered here consists in building predictive models to distin-
guish active from inactive molecules on several protein targets. This problem is naturally formulated as a supervised
binary classification problem that can be solved by SVM.
1Note however that in the case of the Tanimoto kernel (17), the self kernels have to be computed, and the worst case complexity of the algorithm
is O
(
min
(
(np)3, |m|3 + |m′|3
))
.
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Algorithm 2 Sub-routine 1 : initialize walks pointers
INITPOINTERS(Label label)
walkPointers = Pointer[][]
for i = 1, ..., n do
for v ∈ VGi do
if l(v) = label then
walkPointers[i].addPointer(start = v, current = v)
end if
end for
end for
return walkPointers
Algorithm 3 Sub-routine 2 : extend walks pointers
EXTENDPOINTERS(Pointer[][] walkPointersin, Integer depth, Label label1, Label label2)
walkPointersout = Pointer[][]
for i = 1, ..., n do
for ptr ∈ walkPointersin[i] do
for (ptr.current, v) ∈ EGi do
if l(v) = label1 ∧ l
(
(ptr.current, v)
)
= label2 then
if not( depth = 4 ∧ v 6= ptr.start ) then
walkPointersout[i].addPointer(start = ptr.start, current = v)
end if
end if
end for
end for
end for
return walkPointersout
Algorithm 4 Sub-routine 3 : update Gram matrix
UPDATEGRAM(Pointer[][] walkPointers, Float [][] K , String kernelT ype)
for i = 1, ..., n do
for j = 1, ..., n do
if walkPointers[i] 6= [] ∧ walkPointers[j] 6= [] then
if kernelT ype = ’spectrum’ then
update = walkPointers[i].size()× walkPointers[j].size()
else
update = 1
end if
K[i][j] = K[i][j] + update
if i 6= j then
K[j][i] = K[j][i] + update
end if
end if
end for
end for
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TRAIN TEST
Pos Neg Pos Neg
BZR 94 87 63 62
COX 87 91 61 64
DHFR 84 149 42 118
ER 110 156 70 110
Table 1: Basic informations about the datasets considered.
7.1 Datasets
We tested the pharmacophore kernel on several datasets used in a recent SAR study (32). More precisely, we consid-
ered the following four publicly available datasets 2:
• the BZR dataset, a set of 405 ligands for the benzodiazepine receptor,
• the COX dataset, a set of 467 cyclooxygenase-2 inhibitors,
• the DHFR dataset, a set of 756 inhibitors of dihydrofolate reductase,
• the ER dataset, a set of 1009 estrogen receptor ligands.
These datasets contain the 3D structures of the molecules, together with a quantitative measure of their ability to
inhibit a biological mechanism. Datasets were filtered and split into training and test sets according to a particular data
preparation scheme detailed in (32). Table 1 gathers basic informations about the datasets involved in the study.
7.2 Experimental setup
We investigated in this study a simple labeling scheme to describe each atom (hydrogen atoms were systemati-
cally removed), and therefore the potential pharmacophores: the label of an atom is composed of its type (e.g.,
C, O, N ...) and the sign of its partial charge (+,− or 0). Hence the set of labels can be expanded as L ={
C+, C0, C−, O+, O0, O−, . . .
}
. The partial charges account for the contribution of each atom to the total charge
of the molecule, and were computed with the QuacPAC software developed by OpenEye 3. It is important to note that,
contrary to the physicochemical properties of atoms, partial charges depend on the molecule and describe the spatial
distribution of charges. Although the partial charges take continuous values, we simply kept their signs for the labeling
as basic indicators of charges in the description of pharmacophores. We call categorical kernel the kernel resulting
from this labeling, where the kernel between labels KFeat is the Dirac kernel (10) and the kernel between distances
KDist is the Gaussian RBF kernel (9).
Alternatively, we tested several variants of this basic categorical kernel. First, we tested the effect of the partial
charges by removing them from the labels, and keeping the same Dirac and Gaussian RBF kernels for the labels and
distances, respectively. In this case the label of an atom reduces to its type. Second, we tested alternatives to the Dirac
kernel between labels, by taking into account similarities between physicochemical properties of atoms with different
labels. We considered the four following properties, taken from (33) : the Van der Waals radius, which represents the
radius of an imaginary sphere enclosing the atom, the covalent radius, corresponding to half of the distance between
two identical covalently bonded atomic nuclei, the first ionization energy, the energy required to strip it of an electron
from the atom, and the electronegativity, a measure of the ability of an atom or molecule to attract electrons in the
context of a chemical bond. The Van der Waals and covalent radii account for the steric property of atoms, while the
two latter properties encode their electrostatic behavior. In these cases, for computational reasons, a triangular kernel
was used to compare different atoms with respect to these properties. Third, we tested the six fast approximations
mentioned in Section 6 with our original labeling scheme (3- and 2-points spectrum, binary and Tanimoto kernels).
In addition, we tested the state-of-the-art Tanimoto kernel based on the 2D structure of molecules (19) to evaluate
the potential gain obtained by including 3D information. This kernel is defined as the Tanimoto coefficient between
fingerprints indicating the presence or absence of all possible molecular fragments of length up to 8 in the 2D structure
2Available as supporting information of the original study at http://pubs.acs.org/journals/jcisd8/
3http://www.eyesopen.com/products/applications/quacpac.html
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of the molecule, where a fragment refers to a sequence of atoms connected by covalent bonds. We note that this
fingerprint is similar to classical 2D-fingerprints such as the Daylight representation4, with the difference that our
implementation does not require to fold the fingerprint into a small-size vector (18).
The different kernels were implemented in C++, and the SVM experiment was conducted with the freely available
Python machine learning package PyML5. For each experiment, all parameters of the kernel and the SVM were op-
timized over a grid of possible choices on the training set only, to maximize the mean area under the ROC curve
(AUC) (34) over an internal 10-fold cross-validation. The results on the test set correspond to the performance
of the SVM with the selected parameters only. The optimized parameters include the width σ ∈ {0.1, 1, 10} (in
angstroms) of the Gaussian RBF kernel used to compare distances, the soft-margin parameter of the SVM over the
grid {0.1, 0.5, 1, 1.5, ..., 20}, the number of bins used to discretize the distances for the fast approximations over the
grid {4, 6, 8, . . . , 30} and the cut-off parameter C of the triangular kernel when physicochemical properties are used.
This later parameter was chosen among 3 values chosen such that 10, 25 or 50% of all atom pairs in the training set
have a non-zero value for the kernel. The larger C, the more atoms of distinct types are matched by the kernel, but the
longer the kernel computation.
7.3 Results
Table 3 shows the results of classification for the different kernel variants. Each line corresponds to a kernel, and
reports several statistics : the accuracy (fraction of correctly classified compounds), sensitivity (fraction of positive
compounds that were correctly classified), specificity (fraction of negative compounds that were correctly classified),
and AUC. The first line corresponds to the basic categorical kernel. The following five lines show the results of
the five variants of the categorical kernel obtained by modifying the kernel between labels (Dirac kernel for labels
without partial charges, and triangular kernel for 4 physicochemical properties). The results obtained by the six fast
approximations follow. Finally, we added the performance obtained by the state-of-the-art 2D Tanimoto kernel based
on the 2D structure of the molecules and the best results reported in the reference publication (32).
The results of parameters optimization on the training set often led to similar choices for different kernels. For
example, the width of the Gaussian RBF kernel to compare distances was usually selected at 0.1 angstrom, which
corresponds to a very strong constraint on the pharmacophore matching. The cut-off parameter for the triangular
kernel was usually chosen to allow 10 or 25% of matches between atoms on the training set. Finally, the number of
bins selected by the fast approximations to discretize the distances was usually between 20 and 30 bins.
The results show that in general, the five variants of the categorical kernel obtained by modifying the kernel
between labels (lines 2-6) lead to similar or slightly worse performances than the categorical kernel. Removing the
partial charges from atom labels decreases the accuracy by 3 to 5% on all datasets except COX, confirming that
the partial charge information is important for the definition of pharmacophores. The variants based on the four
physicochemical properties of atoms lead to results globally similar to those obtained with atom type labels without
partial charges, from which they are deduced. This shows that, in the context of this study, subtle pharmacophoric
features based on physicochemical parameters instead of simply the type of atoms could not be detected.
The fast pharmacophore kernel obtained by applying a Dirac kernel to check when pairs of candidate pharma-
cophores fall in the same bin of the discretized space (3pt-spectrum) systematically degrades the accuracy of 1 to 5%
over all four datasets compared to the categorical kernel. This suggests that the gain in computation time obtained by
discretizing the space and computing a 3D-fingerprint-like representation of molecules has a cost in terms of accuracy
of the final model. A particular limitation of the fingerprint-based method is that two pharmacophores could remain
unmatched in they fall into two different bins, although they might be very similar but close to the bins boundaries. In
the case of the pharmacophore kernel, such pairs of similar pharmacophores would always be matched.
Interestingly, however, performances competitive with the categorical kernel are obtained by the fast 3pt-binary
and 3pt-Tanimoto kernels. On the BZR dataset, the 3pt-binary kernel even gives the best performance. Contrary to the
3pt-spectrum kernel, these kernels are not pharmacophore kernels in the sense of Definition 2; however they are based
on the same representation as the 3pt-spectrum kernel, the only difference being the way to obtain the kernel value
from the fingerprint description. Note finally that these two kernels give overall similar results.
We observe moreover that except for the COX dataset, the discrete kernels based on two-points pharmacophores
lead to significantly worse results than their three-points counterparts.
4http://www.daylight.com/dayhtml/doc/theory/theory.toc.html
5Available at http://pyml.sourceforge.net
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Exact Discrete
With charges 20’ 6’
Without charges 249’ 7’
Table 2: Computation times in minutes needed to compute the different kernel matrices on the BZR training set. The
first column refers to the computation of the exact kernel (6), and the second one to the approximate kernels (15) and
(17).
For each dataset, the results obtained with the 2D-Tanimoto kernel are significantly worse than those of the cat-
egorical kernel, with a decrease ranging from 3 to 7% on the different datasets. This confirms the relevance of 3D
information for drug activity prediction, that motivated this work. Finally we note that on all but the COX dataset,
the categorical kernel outperforms the best results of (32), confirming the competitiveness of our method compared to
state-of-the-art methods.
Regarding the computational complexity of the different methods, Table 2 shows the time required to compute the
kernel matrices on the BZR training set for different kernels, on a desktop computer, equipped with a Pentium 4 - 3.6
GHz processor, and 1 GB RAM. In the discrete version, the distance range was split into 24 bins, and as expected, the
kernels based on the discretization of the pharmacophore space are faster than their counterparts by a factor of 4 to 35,
depending on the type of labels used (with or without the partial charge information). In the exact kernel computation,
the effect of removing the partial charges from the labels is to induce more matches between atoms and therefore, as
discussed in Section 4, to drastically slow the computation by a factor of 12, consistent with the theoretical estimate
that dividing the size of the label classes by k increases the speed by a factor k3.
8 Discussion and conclusion
This paper presents an attempt to extend the application of recent machine learning algorithms for classification to
the manipulation of 3D structures of molecules. This attempt is mainly motivated by applications in drug activity
prediction, for which 3D pharmacophores are known to play important roles. Although previous attempts to define
kernels for 3D structures (similar in fact to the 2pt-spectrum kernel we tested) led to mixed results (35), we obtained
performance competitive with state-of-the-art algorithms for the categorical kernel based on the comparison of phar-
macophores contained in the two molecules to be compared. This kernel is not an inner product between fingerprints,
and therefore fully exploits the mathematical trick that allows SVM to manipulate measures of similarities rather than
explicit vector representations of molecules, as opposed to other methods such as neural networks. We even observed
that for the closest fingerprint-based approximation obtained by discretizing the space of possible pharmacophores
(3pt-spectrum kernel), the performance significantly decreases. This highlights the benefits that can be gained from
the use of kernels, which provide a satisfactory answer to the common issue of choosing a “good” discretization of
the pharmacophore space to make fingerprints: once discretized, pharmacophores falling on different sides of bins
edges do not match although they might be very close. We notice that approaches based on fuzzy fingerprints (36), for
example, aim at correcting this effect by matching pharmacophores based on different distance bins.
Although the best overall method in this study is the categorical kernel, it is interesting to notice that very compet-
itive results are obtained by the binary and Tanimoto kernels applied to the discretized pharmacophore representation.
Compared to the 3pt-spectrum, the better performance of the binary kernel suggests that the choice of the functional
form of the kernel given a representation of molecules can play a critical role in terms of performance. Representing
pharmacophores by indicators (bits) of their presence rather than by their precise counts can be interpreted as a trivial
way to emphasize rare versus frequent pharmacophores in the kernels. Alternatively, it might be possible for example,
to adopt more flexible schemes to weight the pharmacophores depending on their probability of appearance in the
molecules, and to modify in a similar way the functional form of the pharmacophore kernels (Definition 2) to improve
performance over the categorical kernel.
Concerning the practical use of our approach for screening of large datasets, Table 2 shows that, even for the fastest
variants, the approach based on kernel methods can be computationally demanding even for relatively small datasets.
In practice, however, the time to train the SVM can be smaller than the times presented in Table 2 because not all
entries of the matrix are required. Speeding up SVM and kernel methods for large datasets is currently a topic of
interest in the machine learning community, and applications in virtual screening on large databases of molecules will
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certainly benefit from the advances in this field.
Among the possible extensions to our work, a first direction would be to test and validate different definitions
and labeling for the vertices of the pharmacophores. We limited ourselves to the simplest possible 3-points phar-
macophores based on single atoms annotated by their types and partial charges. The method could be improved by
testing other schemes known to be relevant features as basic components of pharmacophores. Instead of single atoms,
it is for example possible to consider groups of atoms forming functional units instead of single atoms to form phar-
macophores. A second possible extension is to generalize this work to pharmacophores with more points, e.g., 4 or
5. Although several results will not remain valid in this case, such as the expression of the kernel as the trace of a
matrix, this could lead to more accurate models in cases where the binding mechanism is well characterized by such
pharmacophores. Finally, a third promising direction that is likely to be relevant for many real-world applications is
to take into accounts different conformers of each molecule. Indeed, it is well-known that the biological activity to be
predicted is often due to one out of several conformers for a given molecule, which suggests to represent a molecule
not as a single 3D structure but as a set of structures. The kernel approach lends itself particularly well to this exten-
sion, thanks to the possibility to define kernels between sets of structures from a kernel between structures, just like
we defined a kernel between sets of pharmacophores from a kernel between single pharmacophores.
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